US Patent Issued to DiaMedica on June 17 for "Dosage forms of tissue kallikrein 1" (Minnesota Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,805, issued on June 17, was assigned to DiaMedica Inc. (Kelowna, Canada).

"Dosage forms of tissue kallikrein 1" was invented by Rick Pauls (Minnetonka, Minn.) and Todd Verdoorn (Minnetonka, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 Mug/kg to about 10.0 Mug/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for treating ischemic and hemorrhagic conditions."

The patent was filed on Nov. 3, 2023, under Application No. 18/501,8...